ArticleFrontiers in immunology2022

LIMK2 Is a Novel Prognostic Biomarker and Correlates With Tumor Immune Cell Infiltration in Lung Squamous Cell Carcinoma.

Yongcheng Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.